2017 Section 7 Green Book

Otolaryngology–Head and Neck Surgery 154(3)

42. Ishikita T, Oriuchi N, Higuchi T, et al. Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy. Ann Nucl Med . 2010; 24:77-82. 43. Chan JY, Sanguineti G, Richmon JD, et al. Retrospective review of positron emission tomography with contrast- enhanced computed tomography in the posttreatment setting in human papillomavirus–associated oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg . 2012;138:1040-1046. 44. Halpern BS, Yeom K, Fueger BJ, Lufkin RB, Czernin J, Allen-Auerbach M. Evaluation of suspected local recurrence in head and neck cancer: a comparison between PET and PET/ CT for biopsy proven lesions. Eur J Radiol . 2007;62:199-204. 45. Wong RJ, Lin DT, Schoder H, et al. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomo- graphy for recurrent head and neck squamous cell carcinoma. J Clin Oncol . 2002;20:4199-4208. 46. Keyes JW Jr.SUV: standard uptake or silly useless value? J Nucl Med . 1995;36:1836-1839. 47. Lapela M, Eigtved A, Jyrkkio¨ S, et al. Experience in qualita- tive and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer . 2000;36:858-867. 48. Ghanooni R, Delpierre I, Magremanne M, et al. 18F-FDG PET/CT and MRI in the follow-up of head and neck squamous cell carcinoma. Contrast Media Mol Imaging . 2011;6:260-266. 49. Greven KM, Williams DW, Keyes JW, et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer . 1994;74:1355-1359. 50. Kim JW, Roh JL, Kim JS, et al. 18F-FDG PET/CT surveil- lance at 3–6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squa- mous cell carcinoma. Br J Cancer . 2013;109:2973-2979. 51. Lonneux M, Lawson G, Ide C, Bausart R, Remacle M, Pauwels S. Positron emission tomography with fluorodeoxy- glucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope . 2000;110:1493-1497. 52. Purohit BS, Ailianou A, Dulguerov N, Becker CD, Ratib O, Becker M. FDG-PET/CT pitfalls in oncological head and neck imaging. Insights Imaging . 2014;5:585-602. 53. Lango MN, Myers JN, Garden AS. Controversies in surgical management of the node-positive neck after chemoradiation. Semin Radiat Oncol . 2009;19:24-28. 54. Zhou XH. Correcting for verification bias in studies of a diag- nostic test’s accuracy. Stat Methods Med Res . 1998;7:337-353.

head and neck cancer: the utility of PET-CT. Laryngoscope . 2007;117:2129-2134. 31. Ng S-H, Chan S-C, Yen T-C, et al. PET/CT and 3-T whole- body MRI in the detection of malignancy in treated oropharyn- geal and hypopharyngeal carcinoma. Eur J Nucl Med Mol Imaging . 2011;38:996-1008. 32. Porceddu SV, Jarmolowski E, Hicks RJ, et al. Utility of posi- tron emission tomography for the detection of disease in resi- dual neck nodes after (chemo) radiotherapy in head and neck cancer. Head Neck . 2005;27:175-181. 33. Rege S, Maass A, Chaiken L, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracra- nial head and neck cancers. Cancer . 1994;73:3047-3058. 34. Rogers JW, Greven KM, McGuirt WF, et al. Can post–rt neck dissection be omitted for patients with head-and-neck cancer who have a negative pet scan after definitive radiation ther- apy? Int J Radiat Oncol Biol Phys . 2004;58:694-697. 35. Sjovall J, Brun E, Almquist H, Kjellen E, Wahlberg P. Radiotherapy response in head and neck cancer: evaluation of the primary tumour site. Acta Otolaryngol . 2014;134:646-651. 36. Wang YF, Liu RS, Chu PY, et al. Positron emission tomogra- phy in surveillance of head and neck squamous cell carcinoma after definitive chemoradiotherapy. Head Neck . 2009;31:442- 451. 37. Yen TC, Lin CY, Wang HM, et al. 18F-FDG-PET for evalua- tion of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasophar- yngeal carcinoma. Int J Radiat Oncol Biol Phys . 2006;65: 1307-1314. 38. Gupta T, Master Z, Kannan S, et al. Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging . 2011;38:2083-2095. 39. Isles MG, McConkey C, Mehanna HM. A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol . 2008;33: 210-222. 40. Gao S, Li S, Yang X, Tang Q. 18FDG PET-CT for distant metas- tases in patients with recurrent head and neck cancer after defini- tive treatment: a meta-analysis. Oral Oncol . 2014;50:163-167. 41. Fakhry N, Lussato D, Jacob T, Giorgi R, Giovanni A, Zanaret M. Comparison between PET and PET/CT in recurrent head and neck cancer and clinical implications. Eur Arch Otorhinolaryngol . 2007; 264:531-538.

33